Claiborne Cary J 4
4 · ADIAL PHARMACEUTICALS, INC. · Filed Mar 27, 2024
Insider Transaction Report
Form 4
Claiborne Cary J
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-03-25+60,000→ 60,000 totalExercise: $1.35Exp: 2034-03-24→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The option vests pro rata on a monthly basis over 36 months commencing April 25, 2024.